These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26676363)

  • 1. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.
    Li J; Bian EB; He XJ; Ma CC; Zong G; Wang HL; Zhao B
    Int J Oncol; 2016 Feb; 48(2):723-33. PubMed ID: 26676363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA MEG3 Interacts with p53 Protein and Regulates Partial p53 Target Genes in Hepatoma Cells.
    Zhu J; Liu S; Ye F; Shen Y; Tie Y; Zhu J; Wei L; Jin Y; Fu H; Wu Y; Zheng X
    PLoS One; 2015; 10(10):e0139790. PubMed ID: 26444285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.
    Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J
    Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21.
    Li Z; Yang L; Liu X; Nie Z; Luo J
    Biomed Pharmacother; 2018 Aug; 104():181-192. PubMed ID: 29772439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer.
    Dong Z; Zhang A; Liu S; Lu F; Guo Y; Zhang G; Xu F; Shi Y; Shen S; Liang J; Guo W
    Mol Cancer Res; 2017 Jul; 15(7):800-810. PubMed ID: 28539329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and inactivating PI3K/AKT pathway.
    Zhang L; Liang X; Li Y
    Oncol Rep; 2017 Oct; 38(4):2408-2416. PubMed ID: 28791407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer.
    Zhang J; Lin Z; Gao Y; Yao T
    J Exp Clin Cancer Res; 2017 Jan; 36(1):5. PubMed ID: 28057015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of long non-coding RNA MEG3 in nasopharyngeal carcinoma.
    Chak WP; Lung RW; Tong JH; Chan SY; Lun SW; Tsao SW; Lo KW; To KF
    Mol Carcinog; 2017 Mar; 56(3):1041-1054. PubMed ID: 27597634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway.
    Kruer TL; Dougherty SM; Reynolds L; Long E; de Silva T; Lockwood WW; Clem BF
    PLoS One; 2016; 11(11):e0166363. PubMed ID: 27832204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma.
    Gao Y; Huang P; Zhang J
    J Transl Med; 2017 Dec; 15(1):268. PubMed ID: 29287592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation.
    Wang P; Ren Z; Sun P
    J Cell Biochem; 2012 Jun; 113(6):1868-74. PubMed ID: 22234798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer.
    Han F; Liu W; Jiang X; Shi X; Yin L; Ao L; Cui Z; Li Y; Huang C; Cao J; Liu J
    Oncogene; 2015 Aug; 34(33):4391-402. PubMed ID: 25435374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma.
    Zhuo H; Tang J; Lin Z; Jiang R; Zhang X; Ji J; Wang P; Sun B
    Mol Carcinog; 2016 Feb; 55(2):209-19. PubMed ID: 25641194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
    Cheng JC; Auersperg N; Leung PC
    Oncogene; 2011 Sep; 30(37):3930-42. PubMed ID: 21478913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.
    Modali SD; Parekh VI; Kebebew E; Agarwal SK
    Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNMT1-mediated demethylation of lncRNA MEG3 promoter suppressed breast cancer progression by repressing Notch1 signaling pathway.
    Pan T; Ding H; Jin L; Zhang S; Wu D; Pan W; Dong M; Ma X; Chen Z
    Cell Cycle; 2022 Nov; 21(21):2323-2337. PubMed ID: 35822955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel interplay between HOTAIR and DNA methylation in osteosarcoma cells indicates a new therapeutic strategy.
    Li X; Lu H; Fan G; He M; Sun Y; Xu K; Shi F
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2189-2200. PubMed ID: 28730284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma.
    Guo W; Dong Z; Liu S; Qiao Y; Kuang G; Guo Y; Shen S; Liang J
    Mol Carcinog; 2017 Aug; 56(8):1924-1934. PubMed ID: 28345805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA MEG3 activation of p53 mediates ischemic neuronal death in stroke.
    Yan H; Yuan J; Gao L; Rao J; Hu J
    Neuroscience; 2016 Nov; 337():191-199. PubMed ID: 27651151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of adenosine-mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells.
    Liu LX; Deng W; Zhou XT; Chen RP; Xiang MQ; Guo YT; Pu ZJ; Li R; Wang GF; Wu LF
    Int J Oncol; 2016 Jan; 48(1):421-9. PubMed ID: 26647875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.